Monopar Therapeutics Inc.

MNPR | NASDAQ

Price Alert Chart Builder DCF Calculator

$95.72

-$0.75 (-0.78%)

At close: Sep 21, 2026, 4:00 PM ET

$97.94

+$2.22 (+2.32%)

Pre-market: Sep 22, 2026, 8:50 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Cash & Equivalents	61.83M	45.82M	7.27M	8.19M	20.3M	16.74M
Short-Term Investments	78.57M	14.4M	n/a	4.93M	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a	n/a	68.86K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	63.75K	78.87K	66.43K	45.98K	217.75K	62.69K
Total Current Assets	140.46M	60.29M	7.33M	13.17M	20.52M	16.8M
Property-Plant & Equipment	254.92K	n/a	12.65K	61.23K	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	254.92K	n/a	12.65K	61.23K	n/a	68.86K
Total Assets	140.72M	60.29M	7.35M	13.23M	20.52M	16.87M
Account Payables	2.74M	2.25M	1.76M	3.13M	1.58M	1.18M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Liabilities	2.74M	5.25M	1.76M	3.13M	1.58M	1.18M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	154.92K	n/a	n/a	8.41K	n/a	n/a
Total Liabilities	2.89M	5.25M	1.76M	3.14M	1.58M	1.18M
Total Debt	154.92K	n/a	n/a	8.41K	n/a	n/a
Book Value	137.83M	55.04M	5.59M	10.09M	18.94M	15.69M
Book Value Per Share	18.60	4.79	0.39	0.79	1.52	1.43
Common Stock	6.69K	6.1K	14.91K	12.95K	12.6K	11.45K
Retained Earnings	-89.51M	-75.79M	-60.21M	-51.8M	-41.29M	-32.19M
Comprehensive Income	131.39K	35.99K	-14.13K	8.94K	-3.16K	-7.87K
Shareholders Equity	137.83M	55.04M	5.59M	10.09M	18.94M	15.69M
Total Investments	78.57M	14.4M	n/a	4.93M	n/a	n/a